NCT04805892View on ClinicalTrials.gov

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

February 23, 2022

Study Completion Date

February 23, 2022

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

BIOZEK COVID-19 Antigen Rapid Test

The BIOZEK COVID-19 Antigen Rapid Test is used for the detection of SARS-CoV-2 antigens in nasopharyngeal swab specimens from individuals who are suspected of having COVID-19.

Trial Locations (1)

11354

Mobile Covid Services LLC, Flushing

All Listed Sponsors
lead

Mach-E B.V.

INDUSTRY

NCT04805892 - Study Utilizing BIOZEK COVID-19 Antigen Rapid Test. | Biotech Hunter | Biotech Hunter